Cell culture models for studying the development of Barrett's esophagus: A systematic review

Cellular Oncology

Volumn 35, Issue 3, 2012, Pages 149-161

  Bus, P ^a   Siersema, P D ^a   Van Baal, J W P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acid; Barrett's esophagus; Bile salts; Cell lines; In vitro model; Reflux

Indexed keywords

BILE SALT; CYCLOOXYGENASE 2; MUCIN 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR CDX2;

BARRETT ESOPHAGUS; CELL CULTURE; CELL LINE; CELL PROLIFERATION; DISEASE COURSE; ENZYME PHOSPHORYLATION; EPITHELIUM; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW;

ACIDS; BARRETT ESOPHAGUS; BILE ACIDS AND SALTS; CELL CULTURE TECHNIQUES; CELL LINE; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 84867602697     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0076-6     Document Type: Review

References (92)

1. J.P. Galmiche, R.E. Clouse, A. Balint, I.J. Cook, P.J. Kahrilas, W.G. Paterson, A.J. Smout, Functional esophageal disorders. Gastroenterology 130, 1459-1465 (2006)
2. K. Dvorak, R. Fass, R. Dekel, C.M. Payne, M. Chavarria, B. Dvorakova, H. Bernstein, C. Bernstein, H. Garewal, Esophageal acid exposure at pH
3. W.K. Kauer, J.H. Peters, T.R. DeMeester, H. Feussner, A.P. Ireland, H.J. Stein, R.J. Siewert, Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 122, 874-881 (1997) (Pubitemid 27495927)
4. G.M. Eisen, R.S. Sandler, S. Murray, M. Gottfried, The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol. 92, 27-31 (1997) (Pubitemid 27027023)
5. M.A. Eloubeidi, D. Provenzale, Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol. 33, 306-309 (2001) (Pubitemid 32880970)
6. J. Ronkainen, P. Aro, T. Storskrubb, S.E. Johansson, T. Lind, E. Bolling-Sternevald, M. Vieth, M. Stolte, N.J. Talley, L. Agreus, Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129, 1825-1831 (2005) (Pubitemid 41772961)
7. R.J. Playford, New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 55, 442 (2006)
8. J. Lagergren, R. Bergstrom, A. Lindgren, O. Nyren, Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 340, 825-831 (1999) (Pubitemid 29142625)
9. N.J. Shaheen, M.A. Crosby, E.M. Bozymski, R.S. Sandler, Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119, 333-338 (2000) (Pubitemid 30621983)
10. M. Hage, P.D. Siersema, H. van Dekken, E.W. Steyerberg, J. Dees, E.J. Kuipers, Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol. 39, 1175-1179 (2004) (Pubitemid 39656830)
11. H. Pohl, H.G. Welch, The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 97, 142-146 (2005) (Pubitemid 40277094)
12. M.A. Eloubeidi, A.C. Mason, R.A. Desmond, H.B. el-Serag, Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 98, 1627-1633 (2003) (Pubitemid 36875359)
13. D. Nehra, P. Howell, C.P.Williams, J.K. Pye, J. Beynon, Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44, 598-602 (1999) (Pubitemid 29195903)
14. F. Milano, J.W. van Baal, N.S. Buttar, A.M. Rygiel, F. de Kort, C.J. DeMars, W.D. Rosmolen, J.J. Bergman, J. Van Marle, K.K. Wang, M.P. Peppelenbosch, K.K. Krishnadath, Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology 132, 2412-2421 (2007) (Pubitemid 46890856)
15. T.J. Jang, M.Y. Cho, Cyclooxygenase-2 expression and cell proliferation are increased in MUC2-positive area of columnarlined esophagus. Pathol Int. 55, 546-549 (2005) (Pubitemid 41725528)
16. J.W. van Baal, F. Milano, A.M. Rygiel, J.J. Bergman, W.D. Rosmolen, S.J. van Deventer, K.K. Wang, M.P. Peppelenbosch, K.K. Krishnadath, A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology 129, 1274-1281 (2005) (Pubitemid 41446866)
17. Y. Hu, C. Jones, O. Gellersen, V.A. Williams, T.J. Watson, J.H. Peters, Pathogenesis of Barrett esophagus: deoxycholic acid upregulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg. 142, 540-544 (2007) (Pubitemid 46956401)
18. J.W. van Baal, A. Bozikas, R. Pronk, F.J. Ten Kate, F. Milano, A.M. Rygiel, W.D. Rosmolen, M.P. Peppelenbosch, J.J. Bergman, K.K. Krishnadath, Cytokeratin and CDX-2 expression in Barrett's esophagus. Scand J Gastroenterol. 43, 132-140 (2008) (Pubitemid 351161518)
19. K. Bani-Hani, I.G. Martin, L.J. Hardie, N. Mapstone, J.A. Briggs, D. Forman, C.P. Wild, Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst. 92, 1316-1321 (2000) (Pubitemid 30660591)
20. J.M. O'Riordan, M.M. Abdel-Latif, N. Ravi, D. McNamara, P.J. Byrne, G.S. McDonald, P.W. Keeling, D. Kelleher, J.V. Reynolds, Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia- adenocarcinoma sequence in the esophagus. Am J Gastroenterol. 100, 1257-1264 (2005) (Pubitemid 40904346)
21. I. Hritz, H. Gyorffy, B. Molnar, G. Lakatos, F. Sipos, I. Pregun, M. Juhasz, L. Pronai, Z. Schaff, Z. Tulassay, L. Herszenyi, Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment. Pathol Oncol Res. 15, 183-192 (2008)
22. K.K. Krishnadath, H.W. Tilanus, M. van Blankenstein, F.T. Bosman, A.H. Mulder, Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol. 175, 175-180 (1995)
23. J.N. Glickman, P.L. Blount, C.A. Sanchez, D.S. Cowan, V.J. Wongsurawat, B.J. Reid, R.D. Odze, Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus. Hum Pathol. 37, 1304-1315 (2006) (Pubitemid 44380275)
24. C. Tselepis, C.D. Morris, D. Wakelin, R. Hardy, I. Perry, Q.T. Luong, E. Harper, R. Harrison, S.E. Attwood, J.A. Jankowski, Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 52, 174-180 (2003) (Pubitemid 36115055)
25. J.W. van Baal, S.H. Diks, R.J. Wanders, A.M. Rygiel, F. Milano, J. Joore, J.J. Bergman, M.P. Peppelenbosch, K.K. Krishnadath, Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia. Cancer Res. 66, 11605-11612 (2006) (Pubitemid 46094171)
26. C.P. Morales, R.F. Souza, S.J. Spechler, Hallmarks of cancer progression in Barrett's oesophagus. Lancet 360, 1587-1589 (2002) (Pubitemid 35356377)
27. M.C. Palanca-Wessels, M.T. Barrett, P.C. Galipeau, K.L. Rohrer, B.J. Reid, P.S. Rabinovitch, Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology 114, 295-304 (1998) (Pubitemid 28093536)
28. G.N. Stacey, Cell contamination leads to inaccurate data: we must take action now. Nature 403, 356 (2000) (Pubitemid 30073059)
29. J.J. Boonstra, A.W. van der Velden, E.C. Beerens, R. van Marion, Y. Morita-Fujimura, Y. Matsui, T. Nishihira, C. Tselepis, P. Hainaut, A.W. Lowe, B.H. Beverloo, H. van Dekken, H.W. Tilanus, W.N. Dinjens, Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res. 67, 7996-8001 (2007) (Pubitemid 47395132)
30. L.A. Feagins, H.Y. Zhang, K. Hormi-Carver, M.H. Quinones, D. Thomas, X. Zhang, L.S. Terada, S.J. Spechler, R.D. Ramirez, R.F. Souza, Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells. Am J Gastroenterol. 102, 10-20 (2007) (Pubitemid 46072037)
31. N.E. Avissar, L. Toia, Y. Hu, T.J.Watson, C. Jones, D.P. Raymond, A. Matousek, J.H. Peters, Bile acid alone, or in combination with acid, induces CDX2 expression through activation of the Epidermal Growth Factor Receptor (EGFR). J Gastrointest Surg. 13, 212-222 (2008)
32. H. Alvarez, J.B. Koorstra, S.M. Hong, J.J. Boonstra, W.N. Dinjens, T.T. Wu, E. Montgomery, J.R. Eshleman, A. Maitra, Establishment and characterization of a bona fide barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther. 7, 1753-1755 (2008)
33. K. Dvorak, M. Chavarria, C.M. Payne, L. Ramsey, C. Crowley-Weber, B. Dvorakova, B. Dvorak, H. Bernstein, H. Holubec, R.E. Sampliner, C. Bernstein, A. Prasad, S.B. Green, H. Garewal, Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus. Clin Cancer Res. 13, 5305-5313 (2007) (Pubitemid 47510354)
34. K. Dvorak, C.M. Payne, M. Chavarria, L. Ramsey, B. Dvorakova, H. Bernstein, H. Holubec, R.E. Sampliner, N. Guy, A. Condon, C. Bernstein, S.B. Green, A. Prasad, H.S. Garewal, Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 56, 763-771 (2007) (Pubitemid 46854189)
35. G.A. Sarosi Jr., K. Jaiswal, E. Herndon, C. Lopez-Guzman, S.J. Spechler, R.F. Souza, Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3-exchanger. Am J Physiol Gastrointest Liver Physiol. 289, G991-G997 (2005) (Pubitemid 41740602)
36. K. Jaiswal, V. Tello, C. Lopez-Guzman, F. Nwariaku, T. Anthony, G.A. Sarosi Jr., Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line. Surgery 136, 160-168 (2004) (Pubitemid 39037649)
37. K. Jaiswal, C. Lopez-Guzman, R.F. Souza, S.J. Spechler, G.A. Sarosi Jr., Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. Am J Physiol Gastrointest Liver Physiol. 290, G335-G342 (2006)
38. Y. Hao, S. Sood, G. Triadafilopoulos, J.H. Kim, Z. Wang, P. Sahbaie, M.B. Omary, A.W. Lowe, Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure. BMC Gastroenterol. 7, 7-24 (2007)
39. C. Morgan, W. Alazawi, P. Sirieix, T. Freeman, N. Coleman, R. Fitzgerald, In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line. Am J Gastroenterol. 99, 218-224 (2004) (Pubitemid 38279860)
40. R.F. Souza, K. Shewmake, S. Pearson, G.A. Sarosi Jr., L.A. Feagins, R.D. Ramirez, L.S. Terada, S.J. Spechler, Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol. 287, G743-G748 (2004) (Pubitemid 39280431)
41. P.H. Riegman, K.J. Vissers, J.C. Alers, E. Geelen, W.C. Hop, H.W. Tilanus, H. van Dekken, Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res. 61, 3164-3170 (2001) (Pubitemid 32691970)
42. E. Rumiato, G. Pasello, M. Montagna, M.C. Scaini, G.L. De Salvo, A. Parenti, M. Cagol, A. Ruol, E. Ancona, A. Amadori, D. Saggioro, DNA copy number profile discriminates between esophageal adenocarcinoma and squamous cell carcinoma and represents an independent prognostic parameter in esophageal adenocarcinoma. Cancer Lett. 310, 84-93 (2011)
43. Y. Takahashi, Y. Amano, T. Yuki, Y. Mishima, Y. Tamagawa, G. Uno, N. Ishimura, S. Sato, S. Ishihara, Y. Kinoshita, Impact of the composition of gastric reflux bile acids on Barrett's oesophagus. Dig Liver Dis. 43, 692-697 (2011)
44. R. Sharma, F. Majer, V.K. Peta, J. Wang, R. Keaveney, D. Kelleher, A. Long, J.F. Gilmer, Bile acid toxicity structure-activity relationships: correlations between cell viability and lipophilicity in a panel of new and known bile acids using an oesophageal cell line (HET-1A). Bioorg Med Chem. 18, 6886-6895 (2010)
45. P.R. Debruyne, E.A. Bruyneel, X. Li, A. Zimber, C. Gespach, M.M. Mareel, The role of bile acids in carcinogenesis. Mutat Res. 480-481, 359-369 (2001) (Pubitemid 32744842)
46. G.J. Jenkins, F.R. D'Souza, S.H. Suzen, Z.S. Eltahir, S.A. James, J.M. Parry, P.A. Griffiths, J.N. Baxter, Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: The potential role of anti-oxidants in Barrett's oesophagus. Carcinogenesis 28, 136-142 (2007) (Pubitemid 44942637)
47. M.M. Abdel-Latif, J. O'Riordan, H.J. Windle, E. Carton, N. Ravi, D. Kelleher, J.V. Reynolds, NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg. 239, 491-500 (2004) (Pubitemid 38372765)
48. A.J. Jolly, C.P. Wild, L.J. Hardie, Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis 19, 319-324 (2004) (Pubitemid 39028957)
49. T. Liu, X. Zhang, C.K. So, S. Wang, P. Wang, L. Yan, R. Myers, Z. Chen, A.P. Patterson, C.S. Yang, X. Chen, Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. Carcinogenesis 28, 488-496 (2007) (Pubitemid 46321867)
50. X. Huo, H.Y. Zhang, X.I. Zhang, J.P. Lynch, E.D. Strauch, J.Y. Wang, S.D. Melton, R.M. Genta, D.H. Wang, S.J. Spechler, R.F. Souza, Acid and bile salt-induced CDX2 expression differs in squamous cells from patients with and without Barrett's esophagus. Gastroenterology 139, 194-203 (2010)
51. A.H. van Roon, G.C. Mayne, B.P. Wijnhoven, D.I. Watson, M.P. Leong, G.E. Neijman, M.Z. Michael, A.R. McKay, D. Astill, D.J. Hussey, Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa. J Gastrointest Surg. 12, 1331-1340 (2008)
52. X. Huo, S. Juergens, X. Zhang, D. Rezaei, C. Yu, E.D. Strauch, J.Y. Wang, E. Cheng, F. Meyer, D.H. Wang, Q. Zhang, S.J. Spechler, R.F. Souza, Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-kappaB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol. 301, G278-G286 (2011)
53. G.J. Jenkins, J. Cronin, A. Alhamdani, N. Rawat, F. D'Souza, T. Thomas, Z. Eltahir, A.P. Griffiths, J.N. Baxter, The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis 23, 399-405 (2008)
54. A.J. Jolly, C.P. Wild, L.J. Hardie, Sodium deoxycholate causes nitric oxide mediated DNA damage in oesophageal cells. Free Radic Res. 43, 234-240 (2009)
55. T. Soma, J. Kaganoi, A. Kawabe, K. Kondo, S. Tsunoda, M. Imamura, Y. Shimada, Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: a possible mechanism of angiogenesis in patients with esophageal cancer. Int J Cancer 119, 771-782 (2006) (Pubitemid 44051440)
56. J. Wu, J. Gong, J. Geng, Y. Song, Deoxycholic acid induces the overexpression of intestinal mucin, MUC2, via NF-kB signaling pathway in human esophageal adenocarcinoma cells. BMC Cancer 8, 333 (2008)
57. N. Vaninetti, L. Williams, L. Geldenhuys, G.A. Porter, D.L. Guernsey, A.G. Casson, Regulation of CDX2 expression in esophageal adenocarcinoma. Mol Carcinog. 48, 965-974 (2009)
58. D.J. Morrow, N.E. Avissar, L. Toia, E.M. Redmond, T.J. Watson, C. Jones, D.P. Raymond, V. Litle, J.H. Peters, Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells. Surgery 146, 714-721 (2009)
59. S. Song, S. Guha, K. Liu, N.S. Buttar, R.S. Bresalier, COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 56, 1512-1521 (2007) (Pubitemid 350033188)
60. S.P. Duggan, W.M. Gallagher, E.J. Fox, M.M. Abdel-Latif, J.V. Reynolds, D. Kelleher, Low pH induces co-ordinate regulation of gene expression in oesophageal cells. Carcinogenesis 27, 319-327 (2006) (Pubitemid 43159886)
61. H.Y. Zhang, K. Hormi-Carver, X. Zhang, S.J. Spechler, R.F. Souza, In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks. Cancer Res. 69, 9083-9089 (2009)
62. M.C. Carey, Bile acids and bile salts: ionization and solubility properties. Hepatology 4, 66S-71S (1984) (Pubitemid 14018146)
63. A. Roda, A. Fini, Effect of nuclear hydroxy substituents on aqueous solubility and acidic strength of bile acids. Hepatology 4, 72S-76S (1984) (Pubitemid 14018147)
64. A. Fini, A. Roda, Chemical properties of bile acids. IV. Acidity constants of glycine-conjugated bile acids. J Lipid Res. 28, 755-759 (1987)
65. W.K. Kauer, H.J. Stein, Emerging concepts of bile reflux in the constellation of gastroesophageal reflux disease. J Gastrointest Surg 14(Suppl 1), S9-16 (2009)
66. J.W. Harmon, T. Doong, T.R. Gadacz, Bile acids are not equally damaging to the gastric mucosa. Surgery 84, 79-86 (1978) (Pubitemid 8376409)
67. L.A. Feagins, H.Y. Zhang, X. Zhang, K. Hormi-Carver, T. Thomas, L.S. Terada, S.J. Spechler, R.F. Souza, Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am J Physiol Gastrointest Liver Physiol. 294, G411-G417 (2008) (Pubitemid 351253330)
68. A. Goldman, H.D. Chen, H.B. Roesly, K.A. Hill, M.E. Tome, B. Dvorak, H. Bernstein, K. Dvorak, Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis. Am J Physiol Gastrointest Liver Physiol. 300, G292-G302 (2011)
69. A. Goldman, A. Condon, E. Adler, M. Minnella, C. Bernstein, H. Bernstein, K. Dvorak, Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells. Dis Esophagus 23, 83-93 (2010)
70. A.J. Cameron, A.S. Arora, Barrett's esophagus and reflux esophagitis: is there a missing link? Am J Gastroenterol. 97, 273-278 (2002) (Pubitemid 34160749)
71. M. Coenraad, A.A. Masclee, J.W. Straathof, S. Ganesh, G. Griffioen, C.B. Lamers, Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis? Am J Gastroenterol. 93, 1068-1072 (1998) (Pubitemid 29080952)
72. E. Savarino, P. Zentilin, M. Frazzoni, D.L. Cuoco, D. Pohl, P. Dulbecco, E. Marabotto, G. Sammito, L. Gemignani, R. Tutuian, V. Savarino, Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil. 22, 1061-e280 (2010)
73. E. Looby, M.M. Abdel-Latif, V. Athié-Morales, S. Duggan, A. Long, D. Kelleher, Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer 9, 190 (2009)
74. R.N. Keswani, A. Chumsangsri, R. Mustafi, J. Delgado, E.E. Cohen, M. Bissonnette, Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line. Dis Esophagus 21, 514-521 (2008)
75. G. Burnat, T. Rau, E. Elshimi, E.G. Hahn, P.C. Konturek, Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line. Scand J Gastroenterol. 42, 1460-1465 (2007) (Pubitemid 350125549)
76. C. Mariette, G. Piessen, E. Leteurtre, B. Hemon, J.P. Triboulet, I. van Seuningen, Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells andtissues is mediated by the phosphatidylinositol 3-kinase. Surgery 143, 58-71 (2008) (Pubitemid 350266039)
77. G.J. Jenkins, K. Harries, S.H. Doak, A. Wilmes, A.P. Griffiths, J.N. Baxter, J.M. Parry, The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis 25, 317-323 (2004) (Pubitemid 38344397)
78. A.J. Bredenoord, G.J. Hemmink, A.J. Smout, Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterol Motil. 21, 807-812 (2009)
79. M. Bajpai, J. Liu, X. Geng, R.F. Souza, P.S. Amenta, K.M. Das, Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line. Lab Invest. 88, 643-651 (2008) (Pubitemid 351733281)
80. K.M. Das, Y. Kong, M. Bajpai, D. Kulkarni, X. Geng, P. Mishra, D. Banerjee, K. Hirshfield, Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model. Int J Cancer 128, 274-282 (2011)
81. J. Majka, K. Rembiasz, M. Migaczewski, A. Budzynski, A. Ptak-Belowska, R. Pabianczyk, K. Urbanczyk, A. Zub-Pokrowiecka, M. Matlok, T. Brzozowski, Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects. J Physiol Pharmacol. 61, 409-418 (2010)
82. X. Chen, R. Qin, B. Liu, Y. Ma, Y. Su, C.S. Yang, J.N. Glickman, R.D. Odze, N.J. Shaheen, Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 8:1, 1 (2008)
83. E.M. van Soest, J.P. Dieleman, P.D. Siersema, M.C. Sturkenboom, E.J. Kuipers, Increasing incidence of Barrett's oesophagus in the general population. Gut 54, 1062-1066 (2005) (Pubitemid 41025895)
84. T. Bright, A. Schloithe, J.A. Bull, R.J. Fraser, P. Bampton, D.I. Watson, Outcome of endoscopy surveillance for Barrett's oesophagus. ANZ J Surg. 79, 812-816 (2009)
85. N. Fahmy, J.F. King, Barrett's esophagus: an acquired condition with genetic predisposition. Am J Gastroenterol. 88, 1262-1265 (1993) (Pubitemid 23219724)
86. A. Chak, H. Ochs-Balcom, G. Falk, W.M. Grady, M. Kinnard, J.E. Willis, R. Elston, C. Eng, Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 15, 1668-1673 (2006) (Pubitemid 44497103)
87. M. Pera, M.J. Brito, R. Poulsom, E. Riera, L. Grande, A. Hanby, N.A. Wright, Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis 21, 1587-1591 (2000) (Pubitemid 30601650)
88. H. Kumagai, K. Mukaisho, H. Sugihara, M. Bamba, T. Miyashita, K. Miwa, T. Hattori, Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model. Scand J Gastroenterol. 38, 687-692 (2003) (Pubitemid 36920488)
89. M. Raggi, R. Langer, M. Feith, H. Friess, M. Schauer, J. Theisen, Successful evaluation of a new animal model using mice for esophageal adenocarcinoma. Langenbecks Arch Surg. 395, 347-350 (2010)
90. S.E. Attwood, L.A. Harrison, S.L. Preston, J.A. Jankowski, Esophageal adenocarcinoma in "mice and men": back to basics! Am J Gastroenterol. 103, 2367-2372 (2008)
91. K. Pavlov, C.C. Maley, New models of neoplastic progression in Barrett's oesophagus. Biochem Soc Trans. 38, 331-336 (2010)
92. C.J. Buskens, J.B. Hulscher, T.M. van Gulik, F.J. Ten Kate, J.J. van Lanschot, Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. J Surg Res. 135, 337-344 (2006) (Pubitemid 44414894)